These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 342313

  • 21. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
    Profeta ML, Bigatello A, Vacchini V, Bramati L, Ferrante P.
    Boll Ist Sieroter Milan; 1980 Jan 31; 58(6):457-74. PubMed ID: 6778485
    [Abstract] [Full Text] [Related]

  • 22. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R, Chen Q, Zheng L, Chen J, Sui Z, Guan Y, Chen Z.
    Arch Virol; 2009 Jan 31; 154(8):1203-10. PubMed ID: 19543688
    [Abstract] [Full Text] [Related]

  • 23. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI, Furminger IG.
    Dev Biol Stand; 1975 Jan 31; 28():167-72. PubMed ID: 1126566
    [Abstract] [Full Text] [Related]

  • 24. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW, Contreras G, Furesz J.
    Can Med Assoc J; 1979 Apr 07; 120(7):799-802, 831. PubMed ID: 427686
    [Abstract] [Full Text] [Related]

  • 25. Immunization against human and swine-like influenza A: serological response to two inactivated vaccines of different formulation.
    Cuneo-Crovari P, Giacometti G, Gasparini R, Fontana G.
    Boll Ist Sieroter Milan; 1976 Apr 07; 55(5):371-8. PubMed ID: 1016590
    [Abstract] [Full Text] [Related]

  • 26. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.
    Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677
    [Abstract] [Full Text] [Related]

  • 27. Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
    Reichert E, Mauler R.
    Dev Biol Stand; 1975 Jan 29; 28():319-23. PubMed ID: 1126575
    [Abstract] [Full Text] [Related]

  • 28. An electroaerosol device for group vaccination against influenza.
    Grinshpun L, Priimägi L, Subi K, Reinet J, Visnapuu L.
    Z Erkr Atmungsorgane; 1978 Mar 29; 150(3):237-8. PubMed ID: 695738
    [Abstract] [Full Text] [Related]

  • 29. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.
    Kilbourne ED.
    J Infect Dis; 1976 Oct 29; 134(4):384-94. PubMed ID: 789791
    [Abstract] [Full Text] [Related]

  • 30. Editorial: Influenza, the changing virus.
    Med J Aust; 1975 May 03; 1(18):547-8. PubMed ID: 49839
    [No Abstract] [Full Text] [Related]

  • 31. Immunofluorescence study on the prevalence of some respiratory viruses in subjects vaccinated against influenza and in unvaccinated controls.
    Steiner N, Mihăilescu M, Grigore N, Anghelescu S, Ene R.
    Virologie; 1985 May 03; 36(4):289-93. PubMed ID: 3004021
    [Abstract] [Full Text] [Related]

  • 32. Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.
    Kendal AP, Noble GR, Dowdle WR.
    J Infect Dis; 1977 Dec 03; 136 Suppl():S415-24. PubMed ID: 606765
    [Abstract] [Full Text] [Related]

  • 33. Association of serum anti-neuraminidase antibody with resistance to influenza in man.
    Murphy BR, Kasel JA, Chanock RM.
    N Engl J Med; 1972 Jun 22; 286(25):1329-32. PubMed ID: 5027388
    [No Abstract] [Full Text] [Related]

  • 34. Neuraminidase: Another Piece of the Influenza Vaccine Puzzle.
    Eckard LE, Webby RJ.
    J Infect Dis; 2015 Oct 15; 212(8):1180-1. PubMed ID: 25858958
    [No Abstract] [Full Text] [Related]

  • 35. A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
    Jennings R, Potter CW, McLaren C, Brady M.
    J Hyg (Lond); 1975 Dec 15; 75(3):341-52. PubMed ID: 1059704
    [Abstract] [Full Text] [Related]

  • 36. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. a. Influenza viruses].
    Nobusawa E, Nakajima K.
    Nihon Rinsho; 1987 Oct 15; 45(10):2229-34. PubMed ID: 3448262
    [No Abstract] [Full Text] [Related]

  • 37. Influenza immunization: clinical studies with ether-split subunit vaccines.
    Brandon FB, Cox F, Quinn E, Timm EA, McLean IW.
    Bull World Health Organ; 1969 Oct 15; 41(3):629-37. PubMed ID: 5309487
    [Abstract] [Full Text] [Related]

  • 38. Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.
    Beare AS, Schild GC, Craig JW.
    Lancet; 1975 Oct 18; 2(7938):729-32. PubMed ID: 52768
    [Abstract] [Full Text] [Related]

  • 39. Use of recombination in the production of influenza vaccine strains.
    McCahon D, Beare AS, Schild GC, Hall TS.
    Postgrad Med J; 1973 Mar 18; 49(569):195-9. PubMed ID: 4802647
    [Abstract] [Full Text] [Related]

  • 40. Antibody recognition of the influenza virus neuraminidase.
    Air GM, Laver WG, Webster RG, Els MC, Luo M.
    Cold Spring Harb Symp Quant Biol; 1989 Mar 18; 54 Pt 1():247-55. PubMed ID: 2484161
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.